Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 4/20 | 0.61 |
| ▸ | CA1 | P00915 | 3/20 | 0.61 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.57 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.57 |
| ▸ | PARP10 | Q53GL7 | 8/20 | 0.53 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.48 |
| ▸ | PARP4 | Q9UKK3 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | PARP15 | Q460N3 | 1/20 | 0.48 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.48 |
| ▸ | PARP16 | Q8N5Y8 | 1/20 | 0.48 |
| ▸ | PARP11 | Q9NR21 | 1/20 | 0.48 |
| ▸ | PARP1 | P09874 | 3/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | RECQL | P46063 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenol SCHEMBL7153494 | 0.87 | PLA2G10 (0.59) | CA2CA1PLA2G10PLA2G2APARP10 | |
| Benzamide SCHEMBL5499602 | 0.87 | PLA2G10 (0.59) | CA2CA1PLA2G10PLA2G2APARP10 | |
| SCHEMBL5648580 | 0.82 | PLA2G10 (0.53) | CA2CA1PLA2G10PLA2G2APARP10 | |
| SCHEMBL1559089 | 0.80 | CA1 (0.67) | CA2CA1KMT2AALDH1A1MAPT | |
| SCHEMBL7134591 | 0.80 | PLA2G10 (0.83) | CA2CA1PLA2G10PLA2G2APARP10 | |
| Terephthalamide SCHEMBL23774 | 0.79 | PARP1 (0.71) | CA2CA1PLA2G10PLA2G2APARP10 | |
| SCHEMBL2642291 | 0.78 | PLA2G10 (0.59) | CA2CA1PLA2G10PLA2G2APARP10 | |
| SCHEMBL13683319 | 0.78 | CA1 (0.64) | CA2CA1KMT2AALDH1A1TSHR | |
| Terephthalamide SCHEMBL3444098 | 0.78 | LOXL2 (0.60) | CA2PLA2G10PLA2G2APARP10CYP17A1 | |
| SCHEMBL1596773 | 0.78 | CA1 (0.64) | CA2CA1KMT2AALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 204 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116891472-A | Amide derivative containing imidazole structure, and preparation method and application thereof | 延边大学 | 2023-10-17 | — | — | CN | claimed |
| CN-110559299-A | composition containing pyridyl pyrimidinamine compound and application thereof | 黄泳华 | 2019-12-13 | — | — | CN | claimed |
| US-8519040-B2 | Ionic organic compound, production method thereof, hydrogelling agent composed of the ionic organic compound, hydrogel containing same, methanol gelling agent, methanol gel containing same, and carbon nanotube dispersant | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2013-08-27 | — | — | US | claimed |
| US-20110178218-A1 | IONIC ORGANIC COMPOUND, PRODUCTION METHOD THEREOF, HYDROGELLING AGENT COMPOSED OF THE IONIC ORGANIC COMPOUND, HYDROGEL CONTAINING SAME, METHANOL GELLING AGENT, METHANOL GEL CONTAINING SAME, AND CARBON NANOTUBE DISPERSANT | National Institute of Avanced Industrial Science and Technology (JP) | 2011-07-21 | — | — | US | claimed |
| EP-2330143-A1 | IONIC ORGANIC COMPOUND, PRODUCTION METHOD THEREOF, HYDROGELLING AGENT COMPOSED OF THE IONIC ORGANIC COMPOUND, HYDROGEL CONTAINING SAME, METHANOL GELLING AGENT, METHANOL GEL CONTAINING SAME, AND CARBON NANOTUBE DISPERSANT | National Institute of Advanced Industrial Science And Technology (JP) | 2011-06-08 | — | — | EP | claimed |
| CN-1121137-C | Fungicidal compositions containing N-acetonylbenzamides | DAW AGRICULTURAL CO LTD (US) | 2003-09-17 | — | — | CN | claimed |
| EP-1150565-A1 | THIAZOLE DERIVATIVES AND COMBINATORIAL LIBRARIES THEREOF | LION bioscience AG (DE) | 2001-11-07 | — | — | EP | claimed |
| WO-2000045635-A1 | THIAZOLE DERIVATIVES AND COMBINATORIAL LIBRARIES THEREOF | LION BIOSCIENCE AG (DE) | 2000-08-10 | — | — | WO | claimed |
| EP-0116942-B1 | METHOD TO PREPARE 4,4'-BIS-BENZ-OX(THI, -IMID)-AZOL-2-YL STILBENES | HOECHST AKTIENGESELLSCHAFT (DE) | 1986-07-16 | — | — | EP | claimed |
| CN-120629407-A | Method for detecting related substances in imacid dihydrochloride by HPLC (high Performance liquid chromatography) | 远大武药(江苏)制药有限公司 | 2025-09-12 | — | — | CN | disclosed |
| US-20250170117-A1 | MODULATORS OF ACKR3 AND USES THEREOF | INTERAX BIOTECH AG (CH) | 2025-05-29 | — | — | US | disclosed |
| EP-4486739-A1 | MODULATORS OF ACKR3 AND USES THEREOF | InterAx Biotech AG (CH) | 2025-01-08 | — | — | EP | disclosed |
| US-20240308989-A1 | PYRAN DERIVATIVES AS CYP11A1 (CYTOCHROME P450 MONOOXYGENASE 11A1) INHIBITORS | ORION CORP (FI) | 2024-09-19 | — | — | US | disclosed |
| CN-118638077-A | Amide/sulfonamide CXCR4/HDAC dual inhibitor and preparation method and application thereof | 杭州师范大学 | 2024-09-13 | — | — | CN | disclosed |
| WO-1995034595-A1 | ANTIVIRAL DENDRIMERS | BIOMOLECULAR RESEARCH INSTITUTE LTD. (AU) | 1995-12-21 | — | — | WO | disclosed |
| CN-1089595-A | N-acetonyl benzamide and fungicidal action thereof | ROHM & HAAS (US) | 1994-07-20 | — | — | CN | disclosed |
| US-4665073-A | HISTAMINE H2-ANTAGONISTS | ICI AMERICAS INC. (GB) | 1987-05-12 | — | — | US | disclosed |
| EP-0060094-B1 | GUANIDINE DERIVATIVES | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1986-01-22 | — | — | EP | disclosed |
| US-4447441-A | ANTIHISTAMINE, ANTIULCER AND ANTISECRETORY AGENT | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1984-05-08 | — | — | US | disclosed |
| EP-0060094-A2 | Guanidine derivatives | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1982-09-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250170117-A1 | MODULATORS OF ACKR3 AND USES THEREOF | ACKR3, PROKR2, PROKR1 | CA2 2281/4885CA1 3356/4885PLA2G10 3223/4885 |
| US-20240308989-A1 | PYRAN DERIVATIVES AS CYP11A1 (CYTOCHROME P450 MONOOXYGENASE 11A1) INHIBITORS | CYP11B1, CYP11B2, CYP4A11 | CA2 2874/4885CA1 2748/4885PLA2G10 1460/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.